The most efficient services.
The most qualified professionals.
Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.
Learn More About UsStay in the know
Sign up today for the Lachman Consultants blog.
Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.
Three Practices
Executing One Vision
Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.
Get the answers and guidance to your most pressing questions faster than ever before.
Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.
Learn More About Lachman OnCall
The Lachman Consultants Blog
The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.
Halfway Through June 2021, Approval Actions Appear to Hit Sub-Par Numbers
CGT Product Approvals Add Ten (10) Since April 1, 2021
Now that the Unapproved Drug Initiative Is Back on the Horizon, FDA Makes Noise About Unapproved Prescription Thyroid Drugs
Between a Rock and a Hard Place – Accelerated Approval for Alzheimer’s Drug Brings Cheers and Jeers!
OGD Provides Updates to the April 2021 Statistical Report
